| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
ResearchPoint Global is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Access Pro Medical is a supplier of burn and advanced wound care supplies to healthcare facilities.
Caliola Engineering is a woman-owned small business that provides systems, security, and software engineering services to the US Government. They specialize in wireless communications, cryptography, protected MILSATCOM, software defined radio, and unma...
Morse Laboratories is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.